论文部分内容阅读
目的:探讨妊娠期高血压综合征的危险因素分析及治疗效果。方法:选取2012年6月-2014年6月永平县妇幼保健院收治的妊娠期高血压综合征产妇100例为研究对象。回顾性分析所有产妇的临床资料,探讨可能存在造成妊娠期高血压的危险因素。另外,按照治疗方式不同将100例产妇分为观察组与对照组,各50例。给予观察组低分子肝素联合硫酸镁治疗,给予对照组单纯硫酸镁治疗,对比两组的治疗效果。结果:妊高征的发生与产妇年龄、生产次数、流产史、高血压史、家族病史、体重指数存在很大相关性。而接受硫酸镁联合低分子肝素治疗的观察组的总有效率为94.0%,明显高于只接受硫酸镁治疗的对照组80.0%,组间比较差异具有统计学意义(P<0.05)。结论:妊娠期高血压综合征的发生,与产妇年龄、家族病史、肥胖等多种因素有关,并且联合低分子肝素与硫酸镁治疗妊娠期高血压能够取得良好的效果。
Objective: To investigate the risk factors of pregnancy-induced hypertension and its therapeutic effect. Methods: 100 pregnant women with gestational hypertension admitted to YongPei Maternal and Child Health Hospital from June 2012 to June 2014 were selected as the research object. Retrospective analysis of all maternal clinical data to explore the possible risk factors of pregnancy-induced hypertension. In addition, in accordance with the different treatment methods will be divided into 100 cases of maternal observation group and control group, 50 cases each. The observation group was treated with low molecular weight heparin and magnesium sulfate, and the control group was treated with magnesium sulfate alone. The therapeutic effect was compared between the two groups. Results: The incidence of PIH correlated with maternal age, number of births, history of abortion, history of hypertension, family history and body mass index. The total effective rate of the observation group treated with magnesium sulfate and low molecular weight heparin was 94.0%, which was significantly higher than that of the control group treated with magnesium sulfate alone (80.0%). There was significant difference between the two groups (P <0.05). Conclusion: The incidence of Hypertension syndrome in pregnancy is related to maternal age, family history, obesity and other factors, and the combination of low molecular weight heparin and magnesium sulfate in treatment of gestational hypertension can achieve good results.